The Potential Revolution of Cancer Treatment with CRISPR Technology

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Immuno-oncology and targeted therapies have advanced cancer treatment but face challenges like tumor heterogeneity and drug resistance.
• Durable responses remain difficult to achieve, necessitating novel therapeutic strategies.
• There is a critical need for innovative approaches to understand, reverse, and treat carcinogenesis.

Purpose of the Study:

• To review the Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas) 9 technology.
• To provide an overview of current applications of CRISPR/Cas9 in cancer research.
• To discuss the future potential of CRISPR/Cas9 as a cancer therapeutic.

Main Methods:

• Review of existing literature on CRISPR/Cas9 technology and its applications in cancer.
• Analysis of pre-clinical research findings using CRISPR/Cas9 for cancer therapy development.
• Exploration of the challenges and future directions for clinical translation.

Main Results:

• CRISPR/Cas9 is a powerful and efficient genome editing tool with significant therapeutic promise.
• CRISPR/Cas9 has been successfully utilized in pre-clinical cancer research.
• Clinical application of CRISPR/Cas9 for cancer treatment is still in early developmental stages.

Conclusions:

• CRISPR/Cas9 technology holds substantial promise for developing novel cancer therapies.
• Further research and clinical development are required to fully realize the potential of CRISPR/Cas9 in oncology.
• Overcoming challenges in clinical translation is crucial for implementing CRISPR/Cas9-based cancer treatments.